22 March 2019 – Telegraph
Smiths Group is to demerge its under-performing medical unit in an attempt to rejuvenate the business.
Alongside its interim results, the FTSE 100 company sketched out plans for the split first revealed in November, after it failed to agree a tie-up of the medical business with a US rival because of disagreements about valuation.
Ed. WEALTH WARNING – Neither I nor Brunswicks’ are licenced to give financial advice and nothing in this issue, or any other issue of Brunswicks’ Healthcare Review’ should be construed as advice, financial or otherwise, to anyone. Remember that the price of shares can fall as well as increase.